First-in-class of SHMT2 and MTHFD2 inhibitors as antitumor agents Grant US-11384084-B2 United States of America 12 Jul 2022
First-in-class of SHMT2 and MTHFD2 inhibitors as antitumor agents Grant US-10793573-B2 United States of America 06 Oct 2020
FIRST-IN-CLASS OF SHMT2 AND MTHFD2 INHIBITORS AS ANTITUMOR AGENTS Application WO-2019046612-A1 World Intellectual Property Organisation (WIPO) 07 Mar 2019